merck & co. inc. (MRK:New York)
merck & co. inc. (MRK) Snapshot
|
Open
$46.29
|
Previous Close
$46.37
|
|
|
Day High
$46.71
|
Day Low
$45.08
|
|
|
52 Week High
04/24/13 - $48.79
|
52 Week Low
05/23/12 - $37.02
|
|
|
Market Cap
138.9B
|
Average Volume 10 Days
14.6M
|
|
|
EPS TTM
$3.67
|
Shares Outstanding
3.0B
|
|
|
EX-Date
03/13/13
|
P/E TM
12.5x
|
|
|
Dividend
$1.72
|
Dividend Yield
3.69%
|
merck & co. inc. (MRK) Latest News
merck & co. inc. (MRK) Related Businessweek News
merck & co. inc. (MRK) Details
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. It offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, and others. The company also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. In addition, it discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. Further, the company manufactures and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant spray; and products for occasional constipation and frequent heartburn. Additionally, it offers foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has a collaboration with Sanofi Pasteur S.A. and Abide Therapeutics, Inc.; and has a collaboration and license agreement with Luminex Corporation. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
merck & co. inc. (MRK) Top Compensated Officers
merck & co. inc. (MRK) Key Developments
Sanford Heisler LLP has filed a $100 million individual and class action suit in the U.S. District Court for New Jersey against Merck & Co. Inc. (MRK). The action was brought by Kelli Smith on behalf of all female sales representatives at Merck. According to the complaint, the company systematically discriminates against its female and pregnant employees in assignment, promotion, advancement, and pay and retaliates against female employees in violation of Title VII of the US Civil Rights Act, the Lilly Ledbetter Fair Pay Act, the Family and Medical Leave Act and the New Jersey Law Against Discrimination. The complaint asserts that employees on maternity leave are ineligible for merit awards and recognition for their sales, even when their sales surpass those of their male counterparts. According to Smith's legal team, Merck has long been on notice about its company-wide gender and pregnancy discrimination, but has taken no steps to remedy them. In fact, the complaint notes that Merck routinely retaliates against women who raise discrimination complaints.
Merck & Co. Inc. announced that the company has been awarded a significant portion of the UNICEF human papillomavirus (HPV) vaccine tender, and will provide sustained supply of GARDASIL(R) [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] to GAVI-eligible countries. This agreement follows the GAVI Alliance's earlier announcement that HPV vaccines would be included in its portfolio for the first time. GAVI is expected to support the introduction of HPV vaccination in 28 countries by the end of 2017. GAVI Alliance is a public-private partnership focused on saving children's lives and protecting people's health by increasing access to immunization in poor countries. Through this initial tender award, Merck expects to supply approximately 2.4 million doses of GARDASIL to GAVI-eligible countries between 2013 to 2017 to help meet vaccine demand for countries already approved or recommended for approval by GAVI for HPV vaccine demonstration projects and national introductions. Additional awards by UNICEF are anticipated as vaccine demand increases.
Merck announced that the Biologics License Application (BLA) for its investigational ragweed pollen (Ambrosia artemisiifolia) sublingual allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration (FDA). The BLA for Merck's investigational ragweed pollen sublingual allergy immunotherapy tablet is supported by five studies evaluating the efficacy and safety of the tablet in adults, 18 years of age or older, with ragweed induced allergic rhinitis (with or without conjunctivitis).
| Recently Viewed | |||
| MRK:US | $45.99 USD | -0.38 | |
| Company | Last | Change |
| Bayer AG | €84.28 EUR | -0.30 |
| GlaxoSmithKline PLC | 1,713 GBp | +5.00 |
| L'Oreal SA | €135.00 EUR | -1.65 |
| Roche Holding AG | SFr.247.00 CHF | +1.00 |
| Sanofi | €84.50 EUR | -0.12 |
| View Industry Companies | ||
Industry Analysis
MRK
Industry Average
| Valuation | MRK | Industry Range |
| Price/Earnings | 23.6x |
|
| Price/Sales | 3.0x |
|
| Price/Book | 2.6x |
|
| Price/Cash Flow | 23.2x |
|
| TEV/Sales | 2.2x |
|
Post a JobJobs
- Nashua, NH | Merck GroupPosted: May 19
- Rockland, MA | Merck GroupPosted: May 13
- Jaffrey, NH | Merck GroupPosted: May 13
- Jaffrey, NH | Merck GroupPosted: May 17
Sponsored Financial Commentaries
Sponsored Links
To contact MERCK & CO. INC., please visit www.merck.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








